|
1
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Neoptolemos JP, Dunn JA, Stocken DD,
Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli P,
Dervenis C, et al European Study Group for Pancreatic Cancer:
Adjuvant chemoradiotherapy and chemotherapy in resectable
pancreatic cancer: A randomised controlled trial. Lancet.
358:1576–1585. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Girard N, Mornex F, Bossard N, Ychou M,
Chauffert B and Wautot V: Estimating optimal dose of twice-weekly
gemcitabine for concurrent chemoradiotherapy in unresectable
pancreatic carcinoma: Mature results of GEMRT-01 Phase I trial. Int
J Radiat Oncol Biol Phys. 77:1426–1432. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Crane CH, Abbruzzese JL, Evans DB, Wolff
RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters
PW, et al: Is the therapeutic index better with gemcitabine-based
chemoradiation than with 5-fluorouracil-based chemoradiation in
locally advanced pancreatic cancer? Int J Radiat Oncol Biol Phys.
52:1293–1302. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chatterjee S, Willis N, Locks SM, Mott JH
and Kelly CG: Dosimetric and radiobiological comparison of helical
tomotherapy, forward-planned intensity-modulated radiotherapy and
two-phase conformal plans for radical radiotherapy treatment of
head and neck squamous cell carcinomas. Br J Radiol. 84:1083–1090.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Han MW, Lee JC, Choi JY, Kim GC, Chang HW,
Nam HY, Kim SW and Kim SY: Autophagy in hibition can overcome
radio-resistance in breast cancer cells through suppression of TAK1
activation. Anticancer Res. 34:1449–1455. 2014.PubMed/NCBI
|
|
9
|
Kondo Y, Kanzawa T, Sawaya R and Kondo S:
The role of autophagy in cancer development and response to
therapy. Nat Rev Cancer. 5:726–734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maiuri MC, Zalckvar E, Kimchi A and
Kroemer G: Self-eating and self-killing: Crosstalk between
autophagy and apoptosis. Nat Rev Mol Cell Biol. 8:741–752. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mizushima N, Ohsumi Y and Yoshimori T:
Autophagosome formation in mammalian cells. Cell Struct Funct.
27:421–429. 2002. View Article : Google Scholar
|
|
12
|
Liang B, Kong D, Liu Y, Liang N, He M, Ma
S and Liu X: Autophagy inhibition plays the synergetic killing
roles with radiation in the multi-drug resistant SKVCR ovarian
cancer cells. Radiat Oncol. 7:2132012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gewirtz DA, Hilliker ML and Wilson EN:
Promotion of autophagy as a mechanism for radiation sensitization
of breast tumor cells. Radiother Oncol. 92:323–328. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zois CE and Koukourakis MI:
Radiation-induced autophagy in normal and cancer cells: Towards
novel cytoprotection and radio-sensitization policies? Autophagy.
5:442–450. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mendell JT and Olson EN: MicroRNAs in
stress signaling and human disease. Cell. 148:1172–1187. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang P, Chen L, Zhang J, Chen H, Fan J,
Wang K, Luo J, Chen Z, Meng Z and Liu L: Methylation-mediated
silencing of the miR-124 genes facilitates pancreatic cancer
progression and metastasis by targeting Rac1. Oncogene. 33:514–524.
2014. View Article : Google Scholar
|
|
19
|
Oh JS, Kim JJ, Byun JY and Kim IA:
Lin28-let7 modulates radiosensitivity of human cancer cells with
activation of K-Ras. Int J Radiat Oncol Biol Phys. 76:5–8. 2010.
View Article : Google Scholar
|
|
20
|
Wang P, Zhuang L, Zhang J, Fan J, Luo J,
Chen H, Wang K, Liu L, Chen Z and Meng Z: The serum miR-21 level
serves as a predictor for the chemosensitivity of advanced
pancreatic cancer, and miR-21 expression confers chemoresistance by
targeting FasL. Mol Oncol. 7:334–345. 2013. View Article : Google Scholar
|
|
21
|
Hou B, Jian Z, Chen S, Ou Y, Li S and Ou
J: Expression of miR-216a in pancreatic cancer and its clinical
significance. Nan Fang Yi Ke Da Xue Xue Bao. 32:1628–1631. 2012.In
Chinese. PubMed/NCBI
|
|
22
|
Ali S, Banerjee S, Logna F, Bao B, Philip
PA, Korc M and Sarkar FH: Inactivation of Ink4a/Arf leads to
deregulated expression of miRNAs in K-Ras transgenic mouse model of
pancreatic cancer. J Cell Physiol. 227:3373–3380. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Link A, Becker V, Goel A, Wex T and
Malfertheiner P: Feasibility of fecal microRNAs as novel biomarkers
for pancreatic cancer. PLoS One. 7:e429332012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Skvortsov S, Jimenez CR, Knol JC,
Eichberger P, Schiestl B, Debbage P, Skvortsova I and Lukas P:
Radioresistant head and neck squamous cell carcinoma cells:
Intracellular signaling, putative biomarkers for tumor recurrences
and possible therapeutic targets. Radiother Oncol. 101:177–182.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen PJ, Yeh SH, Liu WH, Lin CC, Huang HC,
Chen CL, Chen DS and Chen PJ: Androgen pathway stimulates
microRNA-216a transcription to suppress the tumor suppressor in
lung cancer-1 gene in early hepatocarcinogenesis. Hepatology.
56:632–643. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xia H, Ooi LL and Hui KM:
MicroRNA-216a/217-induced epithelial-mesenchymal transition targets
PTEN and SMAD7 to promote drug resistance and recurrence of liver
cancer. Hepatology. 58:629–641. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu J, Li A, Hong SM, Hruban RH and Goggins
M: MicroRNA alterations of pancreatic intraepithelial neoplasias.
Clin Cancer Res. 18:981–992. 2012. View Article : Google Scholar :
|
|
28
|
Lomonaco SL, Finniss S, Xiang C,
Decarvalho A, Umansky F, Kalkanis SN, Mikkelsen T and Brodie C: The
induction of autophagy by gamma-radiation contributes to the
radioresistance of glioma stem cells. Int J Cancer. 125:717–722.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhuang W, Qin Z and Liang Z: The role of
autophagy in sensitizing malignant glioma cells to radiation
therapy. Acta Biochim Biophys Sin (Shanghai). 41:341–351. 2009.
View Article : Google Scholar
|
|
30
|
He WS, Dai XF, Jin M, Liu CW and Rent JH:
Hypoxia-induced autophagy confers resistance of breast cancer cells
to ionizing radiation. Oncol Res. 20:251–258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chaachouay H, Ohneseit P, Toulany M,
Kehlbach R, Multhoff G and Rodemann HP: Autophagy contributes to
resistance of tumor cells to ionizing radiation. Radiother Oncol.
99:287–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fujiwara K, Iwado E, Mills GB, Sawaya R,
Kondo S and Kondo Y: Akt inhibitor shows anticancer and
radiosensitizing effects in malignant glioma cells by inducing
autophagy. Int J Oncol. 31:753–760. 2007.PubMed/NCBI
|
|
33
|
Kim EJ, Jeong JH, Bae S, Kang S, Kim CH
and Lim YB: mTOR inhibitors radiosensitize PTEN-deficient
non-small-cell lung cancer cells harboring an EGFR activating
mutation by inducing autophagy. J Cell Biochem. 114:1248–1256.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cheng H, Li J, Liu C, Yao W, Xu Y, Frank
TS, Cai X, Shi S, Lu Y, Qin Y, et al: Profilin1 sensitizes
pancreatic cancer cells to irradiation by inducing apoptosis and
reducing autophagy. Curr Mol Med. 13:1368–1375. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang P, Zhang J, Zhang L, Zhu Z, Fan J,
Chen L, Zhuang L, Luo J, Chen H, Liu L, et al: MicroRNA 23b
regulates autophagy associated with radioresistance of pancreatic
cancer cells. Gastroenterology. 145:1133–1143. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Menghini R, Casagrande V, Marino A,
Marchetti V, Cardellini M, Stoehr R, Rizza S, Martelli E, Greco S,
Mauriello A, et al: miR-216a: A link between endothelial
dysfunction and autophagy. Cell Death Dis. 5:e10292014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zou Z, Wu L, Ding H, Wang Y, Zhang Y, Chen
X, Chen X, Zhang CY, Zhang Q and Zen K: microRNA-30a sensitizes
tumor cells to cis-platinum via suppressing beclin 1-mediated
autophagy. J Biol Chem. 287:4148–4156. 2012. View Article : Google Scholar :
|
|
38
|
Chatterjee A, Chattopadhyay D and
Chakrabarti G: miR-17-5p downregulation contributes to paclitaxel
resistance of lung cancer cells through altering beclin1
expression. PLoS One. 9:e957162014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen Y, Li X, Wu X, He C, Guo L, Zhang S,
Xiao Y, Guo W and Tan B: Autophagy-related proteins LC3 and
beclin-1 impact the efficacy of chemoradiation on esophageal
squamous cell carcinoma. Pathol Res Pract. 209:562–567. 2013.
View Article : Google Scholar : PubMed/NCBI
|
